These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4719190)

  • 21. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.
    Welch S; Gebhart SS; Bergman RN; Phillips LS
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1508-18. PubMed ID: 2229309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol and blood glucose: simultaneous measurements over a wide range of doses and the effect of propranolol on the glucose tolerance test.
    Staniforth DH; Yorkston NJ; Gemidjioglu M
    Eur J Clin Pharmacol; 1980 Jun; 17(6):415-8. PubMed ID: 6995133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic responses to fasting and ethanol infusion in obese, diabetic subjects. Relationship to insulin deficiency.
    Kalkhoff RK; Kim HJ
    Diabetes; 1973 May; 22(5):372-80. PubMed ID: 4700050
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum insulin in obesity and diabetes mellitus.
    Boshell BR; Chandalia HB; Kreisberg RA; Roddam RF
    Am J Clin Nutr; 1968 Dec; 21(12):1419-28. PubMed ID: 5724820
    [No Abstract]   [Full Text] [Related]  

  • 27. Aging and insulin resistance in a group of nonobese male volunteers.
    Kimmerling G; Javorski WC; Reaven GM
    J Am Geriatr Soc; 1977 Aug; 25(8):349-53. PubMed ID: 874246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of enteric hormones on insulin secretion.
    Kahil ME; McIlhaney GR; Jordan PH
    Metabolism; 1970 Jan; 19(1):50-7. PubMed ID: 5410662
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo.
    Gottesman I; Mandarino L; Gerich J
    Diabetes; 1984 Feb; 33(2):184-91. PubMed ID: 6363173
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and metabolic features of subjects with glucose intolerance and high fasting glucose levels].
    Arteaga Llona A; Pollak F; Robres L; Velasco N
    Rev Med Chil; 2009 Feb; 137(2):193-9. PubMed ID: 19543640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between metabolic responses to fasting in obese diabetic and obese nondiabetic subjects.
    Jackson RA; Moloney M; Lowy C; Wright AD; Hartog M; Pilkington TR; Fraser TR
    Diabetes; 1971 Apr; 20(4):214-27. PubMed ID: 4927927
    [No Abstract]   [Full Text] [Related]  

  • 34. Obesity does not modulate insulin secretion in Indian patients with non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    Diabetes Care; 1984; 7(1):77-9. PubMed ID: 6368154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of type II diabetes mellitus.
    Nagulesparan M; Savage PJ; Bennion LJ; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1981 Sep; 53(3):560-8. PubMed ID: 7021580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma insulin and free fatty acids in young people with postprandial glycosuria: plasma insulin response in the cases with borderline glucose tolerance test.
    Goto Y; Sato S; Oira S; Maruhama Y
    Diabetologia; 1973 Aug; 9(4):264-7. PubMed ID: 4767365
    [No Abstract]   [Full Text] [Related]  

  • 37. Further evidence that insulin resistance exists in patients with chemical diabetes.
    Ginsberg H; Olefsky JM; Reaven GM
    Diabetes; 1974 Aug; 23(8):674-8. PubMed ID: 4852112
    [No Abstract]   [Full Text] [Related]  

  • 38. [Obesity and diabetes. I. Blood sugar, blood insulin and NEFA during glucose tolerance test in obese subjects].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1969; 31(1):40-8. PubMed ID: 5402437
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.